News

CSL Biotherapies (CSL) has initiated the US clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Reportedly, studies will determine the safety of CSL’s candidate vaccine and its

Novartis has reported that the European Commission (EC) has approved Xolair (omalizumab) as add-on therapy for severe persistent allergic asthma in children aged 6 to 11 years. Reportedly,

RegeneRX Biopharmaceuticals has received a Notice of Allowance in Europe for its application – Inhibition or Reversal of Skin Aging by Actin-Sequestering Peptides. Reportedly, the patent covers methods,

Nutra Pharma, a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has submitted final packaging and labeling to the Food and Drug

ARIAD Pharmaceuticals and its co-plaintiffs have announced that the US Court of Appeals for the Federal Circuit has granted their petition for rehearing en banc, and has vacated

Eric Shinseki, secretary of Veterans Affairs, is planing to lease 2.4 acres to a private-sector medical facility. The lease is in exchange for construction of building for the

Osteologix has reported that the Japan Patent Office (JPO) has issued a decision to grant a patent for application number 2006-504379: Treating Cartilage/Bone Conditions with Water-Soluble Strontium Salts.

NovaDel Pharma has received a payment of approximately $150,000 from Velcera, relating to its License and Development Agreement with Velcera dated June 22, 2004. Reportedly, the agreement provides

Procter & Gamble and Warner Chilcott have sealed an agreement for the sale of P&G’s global pharmaceuticals business to Warner Chilcott for a cash payment of $3.1 billion.